Price Chart

Profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
URL http://www.hologic.com
Investor Relations URL https://investors.hologic.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Value
Next Earnings Release Oct. 31, 2023 (est.)
Last Earnings Release Jul. 31, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in five segments: diagnostics (60% of total sales, boosted by pandemic), breast health (14% of sales, suppressed by pandemic), surgical (11%), and skeletal health (1%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
URL http://www.hologic.com
Investor Relations URL https://investors.hologic.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Medical Instruments & Supplies
Equity Style Mid Cap/Value
Next Earnings Release Oct. 31, 2023 (est.)
Last Earnings Release Jul. 31, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A